医学
经济评价
肺结核
重症监护医学
成本效益分析
肺结核
经济影响分析
诊断试验
成本效益
经济模型
梅德林
系统回顾
GeneXpert MTB/RIF公司
临床前试验
风险分析(工程)
经济分析
经济成本
结核病诊断
作者
Natthakan Chitpim,Panida Yoopetch,Jiraphun Jittikoon,Wanvisa Udomsinprasert,Kornkanok Bunwong,Surakameth Mahasirimongkol,Usa Chaikledkaew
摘要
Recent evidence supports the cost-effectiveness and cost-saving of Xpert MTB/RIF and TB-LAMP for diagnosing adult pulmonary TB. Policymakers should prioritize reducing cartridge costs and implementing models that capture patient-level benefits to maximize economic benefits.
科研通智能强力驱动
Strongly Powered by AbleSci AI